1-12 of 12
Erika Florendo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety in Patients with Lenalidomide-Refractory Multiple Myeloma after 1-3 Prior Lines Who Received a Single Infusion of Ciltacabtagene Autoleucel As Study Treatment in the Phase 3 CARTITUDE-4 Trial

M Hasib Sidiqi, Paolo Corradini, Duncan Purtill, Hermann Einsele, Binod Dhakal, Lionel Karlin, Salomon Manier, Shinsuke Iida, Sebastian Giebel, Simon J. Harrison, Brea Lipe, Abdullah Khan, Jordan M. Schecter, Carolyn Chang Jackson, Tzu-min Yeh, Arnob Banerjee, William Deraedt, Nikoletta Lendvai, Carolina Lonardi, Ana Slaughter, Katherine Li, Diana Chen, Jane Gilbert, Tito Roccia, Man Zhao, Nitin Patel, Erika Florendo, Mythili Koneru, Octavio Costa Filho, Dong Geng, Jesus San Miguel, Kwee Yong
Journal: Blood
Blood (2023) 142 (Supplement 1): 4866.
https://doi.org/10.1182/blood-2023-178778
Published: 2023
Journal Articles

Clinical Experience with Cranial Nerve Impairment in the CARTITUDE-1, CARTITUDE-2 Cohorts A, B, and C, and Cartitude-4 Studies of Ciltacabtagene Autoleucel (Cilta-cel)

Niels W.C.J. Van De Donk, Surbhi Sidana, Jordan M. Schecter, Carolyn Chang Jackson, Nikoletta Lendvai, Kevin C De Braganca, Ana Slaughter, Carolina Lonardi, Philip Vlummens, Helen Varsos, Christina Corsale, Deepu Madduri, Shirin Jadidi, Junchen Gu, Hao Zhao, Katherine Li, Erin Lee, Loreta Marquez, Man Zhao, Tzu-min Yeh, Diana Chen, Erika Florendo, Nitin Patel, Muhammad Akram, Jaime Gellego Perez-Larraya, Paula Rodriguez Otero
Journal: Blood
Blood (2023) 142 (Supplement 1): 3501.
https://doi.org/10.1182/blood-2023-178743
Published: 2023
Journal Articles

DVRd Followed By Ciltacabtagene Autoleucel Versus DVRd Followed By ASCT in Patients with Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible: A Randomized Phase 3 Study ( EM agine/CARTITUDE-6)

Mario Boccadoro, Jesús San-Miguel, Kenshi Suzuki, Niels W.C.J. Van De Donk, Gordon Cook, Andrzej Jakubowiak, Deepu Madduri, Salma Afifi, An-Sofie Stevens, Jordan M. Schecter, William Deraedt, Steven Kuppens, Pankaj Mistry, Lida Pacaud, Erika Florendo, Annemiek Broijl, Francesca Gay, Roberto Mina, Leo Rasche, Philippe Moreau, María-Victoria Mateos, Hermann Einsele, Pieter Sonneveld
Journal: Blood
Blood (2022) 140 (Supplement 1): 4630–4632.
https://doi.org/10.1182/blood-2022-157021
Published: 2022
Journal Articles

Characteristics and Outcomes in Patients with Lenalidomide-Refractory Relapsed/Refractory Multiple Myeloma Treated with 1-3 Prior Lines of Therapy: Analysis of the Individual Patient-Level Data from Daratumumab Clinical Trials

Binod Dhakal, Hermann Einsele, Jordan M Schecter, Tito Roccia, William Deraedt, Nikoletta Lendvai, Ana Slaughter, Carolina Lonardi, Kaitlyn Connors, Keqin Qi, Anil Londhe, Robin Carson, Jennifer Voelker, Patricia Cost, Satish Valluri, Erika Florendo, Lida Pacaud, Kwee Yong
Journal: Blood
Blood (2022) 140 (Supplement 1): 4320–4322.
https://doi.org/10.1182/blood-2022-159151
Published: 2022
Journal Articles

Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed By Ciltacabtagene Autoleucel Versus Vrd Followed By Lenalidomide and Dexamethasone (Rd) Maintenance in Patients with Newly Diagnosed Multiple Myeloma Not Intended for Transplant: A Randomized, Phase 3 Study (CARTITUDE-5)

Dominik Dytfeld, Binod Dhakal, Mounzer Agha, Salomon Manier, Michel Delforge, Steven Kuppens, Salma Afifi, William Deraedt, Agne Taraseviciute-Morris, Jordan M. Schecter, Jane Gilbert, Fevzi Yalniz, Erika Florendo, Lida Pacaud, Vania Hungria, Saad Z. Usmani, Maria-Victoria Mateos
Journal: Blood
Blood (2021) 138 (Supplement 1): 1835.
https://doi.org/10.1182/blood-2021-146210
Published: 2021
Journal Articles

Characterization and Management of Oral and Dermatological Toxicities in Patients Receiving the CD3 X GPRC5D Bispecific Antibody Talquetamab (JNJ-64407564) for the Treatment of Relapsed and/or Refractory Multiple Myeloma

Stefania Stefania Mancia, Annamaria Farrell, Karen Louw, Erika Florendo, Elizabeth Aronson, Kiah Purcell, Donna D Catamero, Juliet Escalon, Joanne Thomas, Annel Aponte, Angela Lamb, Diana Kirke, Aimee Lucas, Sundar Jagannath, Hearn Jay Cho, Samir Parekh, Joshua Richter, Larysa Sanchez, Ajai Chari
Journal: Blood
Blood (2021) 138 (Supplement 1): 1658.
https://doi.org/10.1182/blood-2021-153817
Published: 2021
Journal Articles

Phase 1 Study of Elotuzumab and Peripheral Blood Mononuclear Cell Reconstitution in Combination with Autologous Stem Cell Transplantation and Lenalidomide Maintenance for Multiple Myeloma

Keren Osman, MD, Ajai Chari, Samir Parekh, MD, Adolfo Aleman, Jessica Caro, MD, Gillian Morgan, RN, Erika Florendo, NP, Elaine Chan, Gina Strumolo, Katarzyna Zarychta, Lisa La, BS, MS, John Mandeli, PhD, Seunghee Kim-Schultze, PhD, Sacha Gnjatic, PhD, Sundar Jagannath, MD, Hearn Jay Cho, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3282.
https://doi.org/10.1182/blood.V130.Suppl_1.3282.3282
Published: 2017
Journal Articles

Phase 1 Study of Elotuzumab in Combination with Autologous Stem Cell Transplantation and Lenalidomide Maintenance for Multiple Myeloma

Keren Osman, MD, Ajai Chari, MD, Samir Parekh, MD, Christine Pun, BS, Gillian Morgan, RN, Erika Florendo, ANP-BC, Elaine Chan, BS, Marisa Shields, Gina Strumolo, MA, Lisa La, MS/CCRP, John Mandeli, PhD, James Geerlof, BS, PA, Sundar Jagannath, MD, Hearn Jay Cho, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3448.
https://doi.org/10.1182/blood.V128.22.3448.3448
Published: 2016
Journal Articles

A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma

Ajai Chari, MD, Hearn Jay Cho, MD PhD, Samir Parekh, MD, Kenneth Lau, Gillian Morgan, RN, Donna Catamero, ANP-BC, Melissa Cortes, AGPCNP-BC, Meredith Curtis, AGPCNP-BC, Juliet Escalon, NP, Erika Florendo, ANP-BC, Daniel Verina, ACNP-BC, Nadege Stevens, RN, Elaine Chan, BS, Katarzyna Garcia, MS / CCRP, Lisa La, MS/CCRP, Marisa Shields, Gina Strumolo, MA, Sundar Jagannath, MD
Journal: Blood
Blood (2016) 128 (22): 4520.
https://doi.org/10.1182/blood.V128.22.4520.4520
Published: 2016
Journal Articles

Outcomes and Management of Red Blood Cell Transfusions in Multiple Myeloma Patients Treated with Daratumumab

Ajai Chari, MD, Toshihisa Satta, Amit Tayal, Sundar Jagannath, MD, Hearn Jay Cho, MD PhD, Samir Parekh, MD, Kenneth Lau, Gillian Morgan, Donna Catamero, Juliet Escalon, Erika Florendo, Daniel Verina, Parul Doshi, Huaibao Feng, Clarissa Uhlar, Imran Khan, Tahamtan Ahmadi, Peter M. Voorhees, Maria-Victoria Mateos, Suzanne Arinsburg
Journal: Blood
Blood (2015) 126 (23): 3571.
https://doi.org/10.1182/blood.V126.23.3571.3571
Published: 2015
Journal Articles

A Phase II Study of Panobinostat with Lenalidomide and Weekly Dexamethasone in Myeloma

Ajai Chari, MD, Hearn Jay Cho, MD PhD, Siyang Leng, MD, Amishi Dhadwal, BS, Gillian Morgan, Lisa La, MS/CCRP, Katarzyna Garcia, MS / CCRP, Crystle Carter, RN, Donna Catamero, Juliet Escalon, Erika Florendo, Nadege Stevens, RN, Daniel Verina, Moon-hee Yum, RN, Jude Gullie, BA, Elaine Chan, BS, Sundar Jagannath, MD, Violetta V Leshchenko, PhD, Alessandro Lagana, PhD, Jingjing Qi, Manishkumar Patel, Kim-Schulze Seunghee, Samir Parekh, MD
Journal: Blood
Blood (2015) 126 (23): 4226.
https://doi.org/10.1182/blood.V126.23.4226.4226
Published: 2015
Journal Articles

Recapturing Disease Response: A Phase II Study of High Dose Carfilzomib in Patients with Relapsed or Refractory Multiple Myeloma Who Have Progressed on Standard Dose Carfilzomib

Ajai Chari, MD, Hearn Jay Cho, MD PhD, Samir Parekh, MD, Keren Osman, MD, Talia Goldstein, BA, Gillian Morgan, Lisa La, MS/CCRP, Crystle Carter, RN, Donna Catamero, Juliet Escalon, Daniel Verina, Erika Florendo, Moon-hee Yum, RN, Nadege Stevens, RN, Jude Gullie, BA, Elaine Chan, BS, Sundar Jagannath, MD
Journal: Blood
Blood (2015) 126 (23): 3051.
https://doi.org/10.1182/blood.V126.23.3051.3051
Published: 2015